Earnings Insights

Fedbank Financi. Q4 FY26 quarterly results analysis. - Gold loan AUM growth is expected to continue strongly, supported by 113 new branches and a focus on tonnage growth, targeting a 10% to 12% CAGR in gold loan tonnage year-on-year. Market Cap ₹5,599, P/E 14.6. AI-powered earnings insights.

6 Aug 2026

Fedbank Financi. Q3 FY26 quarterly results analysis. - Fedbank Financial Services anticipates strong growth in FY '27 and FY '28, supported by significant branch expansion and strategic initiatives. Market Cap ₹5,599, P/E 14.6. AI-powered earnings insights.

6 Aug 2026

Fedbank Financi. Q1 FY26 quarterly results analysis. - AUM growth is expected at 12%-15% including business loans; excluding business loans, LAP and gold loans are targeted to grow 25%-30% annually. Market Cap ₹5,599, P/E 14.6. AI-powered earnings insights.

6 Aug 2026

Cello World Q2 FY26 quarterly results analysis. - Cello World guides for overall revenue growth of 12% to 15% for FY '26. Market Cap ₹8,812, P/E 26.1. AI-powered earnings insights.

6 Aug 2026

Max Estates Q2 FY26 quarterly results analysis. - Max Estates targets cumulative pre-sales of Rs. Market Cap ₹6,466, P/E N/A. AI-powered earnings insights.

6 Aug 2026

Max Estates Q1 FY26 quarterly results analysis. - Max Estates targets presales growth of 15% to 20% CAGR over the coming years. Market Cap ₹6,466, P/E N/A. AI-powered earnings insights.

6 Aug 2026

Honasa Consumer Ltd Q2 FY26 quarterly results analysis. - Honasa Consumer expects double-digit value growth for the remaining part of FY26, driven by focus categories now contributing over 80% of revenues and growing in double digits across channels. Market Cap ₹14,986, P/E 73.6. AI-powered earnings insights.

6 Aug 2026

Honasa Consumer Ltd Q4 FY25 quarterly results analysis. - Honasa Consumer aims to double its revenue by the end of the decade, targeting over INR 4,000 crores. Market Cap ₹14,986, P/E 73.6. AI-powered earnings insights.

6 Aug 2026

Cello World Q4 FY26 quarterly results analysis. - Near term (next 2 quarters): Expected growth of about 8% to 10%, with steelware still under some pressure and ramping up. Market Cap ₹8,812, P/E 26.1. AI-powered earnings insights.

6 Aug 2026

Cello World Q3 FY26 quarterly results analysis. - The company aims to achieve sales around INR 400 crores from the Cello brand acquisition by FY 2027, focusing on profitable growth rather than just top-line expansion. Market Cap ₹8,812, P/E 26.1. AI-powered earnings insights.

6 Aug 2026

Gravita India Ltd Q4 FY26 quarterly results analysis. - Gravita targets a volume CAGR of over 25% through FY 2028 and beyond. - FY 2027 and FY 2028 volume growth is expected to improve, supported by capacity expansions coming live in Q4 of FY 2026 and ramp-up by Q2 FY 2027. - Lead volumes are expected to ramp up fully

6 Aug 2026

Gravita India Ltd Q2 FY26 quarterly results analysis. No information is provided regarding the same in the latest conference call. Market Cap ₹12,465, P/E 31.8. AI-powered earnings insights.

6 Aug 2026

Gravita India Ltd Q4 FY25 quarterly results analysis. - Gravita targets a volume CAGR of around 25% year-on-year growth over the next 3-4 years. Market Cap ₹12,465, P/E 31.8. AI-powered earnings insights.

6 Aug 2026

Grasim Industries Ltd Q3 FY26 quarterly results analysis. - **Paints Business (Birla Opus):** - Confident of reaching double-digit market share in Q4 FY '26 or Q1 FY '27. Market Cap ₹220,104, P/E 44.0. AI-powered earnings insights.

6 Aug 2026

Blue Jet Healthcare Ltd Q4 FY26 quarterly results analysis. - The gadolinium-based NCE product is expected to reach a steady state with stable and sustainable yearly sales; modest growth possible in FY27 (Page 17). Market Cap ₹11,190, P/E 47.6. AI-powered earnings insights.

6 Aug 2026

Blue Jet Healthcare Ltd Q3 FY26 quarterly results analysis. - The company anticipates stable to growing order book momentum with strong medium to long-term visibility fueled by global customer commitments. Market Cap ₹11,190, P/E 47.6. AI-powered earnings insights.

6 Aug 2026

Blue Jet Healthcare Ltd Q1 FY26 quarterly results analysis. - Cardiovascular intermediate molecule showing strong growth, with 9,000 cardiologists in the US prescribing it and expansion into new markets like Canada; expected to grow from a new base of Rs. Market Cap ₹11,190, P/E 47.6. AI-powered earnings insights.

6 Aug 2026

Nuvama Wealth Management Ltd Q4 FY26 quarterly results analysis. - Targeting overall business growth between 20% to 25% once the base is formed. Market Cap ₹30,605, P/E 28.3. AI-powered earnings insights.

6 Aug 2026

Nuvama Wealth Management Ltd Q2 FY26 quarterly results analysis. - Wealth Management and Asset Management businesses are expected to grow faster than last year. Market Cap ₹30,605, P/E 28.3. AI-powered earnings insights.

6 Aug 2026

Nuvama Wealth Q1 FY26 quarterly results analysis. - Wealth business lending book expected to grow by about 20% YoY, targeting INR1,800-2,000 crores growth by end FY26 (Page 18). Market Cap ₹30,609, P/E 28.3. AI-powered earnings insights.

5 Aug 2026